Skip to main content

From Flies to Families

From Flies to Families: How a Gene Variant May Shield Against Seizures


Researchers identified a genetic modifier of PIGA-CDG, a rare disorder that results in seizures, in a family carrying the genetic mutation and in a fruit fly model.

Gregor Mendel’s studies of inheritance patterns in pea plants helped shape researchers’ understanding of single-gene diseases, which can run in families. Some of the diseases that follow a Mendelian pattern include cystic fibrosis, color blindness, and rare seizure disorders such as phosphatidylinositol glycan class A congenital disorder of glycosylation (PIGA-CDG).

Clement Chow, a geneticist at the University of Utah Health, and his team study the role of genetic variants on disease outcomes, especially in rare diseases. Chow focused on PIGA-CDG when he and his team noticed a family carrying the PIGA mutation where some members remained unaffected by the disease. This finding led them to search for a genetic modifier that might contribute to this observation.

The researchers identified the contactin-2 (CNTN2) gene, which appeared in healthy family members with PIGA mutations. Their findings, published in The American Journal of Human Genetics, revealed that CNTN2 may be a protective genetic modifier in this disease.1 Identifying rare disease modifier genes in families could also aid in developing therapeutic targets.

While PIGA-CDG is caused by a mutation in the PIGA gene on the X chromosome, its expression varies and manifests in different symptoms. There are fewer than 100 reported individuals with the disorder, underscoring a need to better understand PIGA-CDG.

In the studied family, two brothers with PIGA-CDG developed early-onset epilepsy and mild developmental delay. Genetic testing revealed they both inherited the same PIGA variant.2 Notably, their maternal grandfather and a great-uncle also carried the variant but remained asymptomatic. Chow hypothesized that genetic modifiers might play a role in this discrepancy.

Using whole-genome sequencing and pedigree analysis of the family members, the researchers identified candidate modifier genes based on inheritance pattern: protective in healthy genetic carriers and susceptibility in those with PIGA-CDG. The team identified roughly 30 variants for each and then made a shortlist based on the predicted function of the genes involved in glycosylphosphatidylinositol (GPI) anchors.

PIGA encodes for a protein necessary for making GPI anchors, which are essential in attaching proteins to the cell membrane. Without GPI-anchored proteins, cell adhesion, signal transduction, and protection from immune destruction are affected. Based on this criterion, the researchers narrowed their list to three candidate genes.

Using a Drosophila melanogaster eye model, the team tested how the candidate genes influenced PIGA loss in vivo. Since PIGA knockdown significantly reduces eye size, researchers used this trait to assess gene interactions. The predicted protective modifiers were expected to rescue (make the eye bigger), while susceptibility candidates were expected to enhance (make the eye smaller) the PIGA phenotype. Notably, CNTN2, a GPI-anchored protein involved in neuron-glial cell interaction, was a strong protective genetic modifier, rescuing an eye size defect in the flies caused by the loss of PIGA.

The researchers also tested the motor effects of PIGA neuronal knockdown flies–known to have seizures and difficulty moving—such as climbing to the top of a vial. Flies with reduced function for both PIGA and Cont, the fruit fly ortholog to CNTN2, appeared to move more readily and showed reduced severity of seizures.

Based on these findings, the researchers believe that changes to CNTN2 are likely to protect people against the disease. With further investigations between affected families, this finding could eventually lead to a better grasp of understudied rare disorders and the development of therapies for PIGA-CDG.

“If we can use this strategy more broadly, I think we can help address the problem of phenotypic variation in rare disease,” Chow said in a press release. “I am hoping that this will be used as a roadmap moving forward.”

gene variant, seizures, epilepsy, neurological disorders, genetic mutation, ion channels, brain function, neuroprotection, synaptic transmission, hereditary traits, nervous system, neuronal excitability, seizure resistance, epilepsy research, genetic influence, neurogenetics, fruit flies, model organisms, familial epilepsy, brain signaling

#GeneVariant #Seizures #Epilepsy #NeurologicalDisorders #GeneticMutation #IonChannels #BrainFunction #Neuroprotection #SynapticTransmission #HereditaryTraits #NervousSystem #NeuronalExcitability #SeizureResistance #EpilepsyResearch #GeneticInfluence #Neurogenetics #FruitFlies #ModelOrganisms #FamilialEpilepsy #BrainSignaling

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...
Post a Comment
Read more